Sonya Bhatia, Ph.D., is Director of Life Sciences Investments at a single-family office in Silicon Valley, focusing on biotechnology and healthcare investments in central nervous system disorders. She was previously a Vice President on the Life Sciences Investments team at Goldman Sachs and holds a Ph.D. in Genetics from Harvard University.